recall
FDA launches drug shortages app
March 6, 2015Medical Communications, Sales and Marketing Apple, FDA, app, drug, google, play, recall, shortages
The US Food and Drug Administration has launched its first smartphone app which provides valuable information about drug shortages. The …
Sun Pharma and Ranbaxy merger gets US nod
February 2, 2015Manufacturing and Production, Sales and Marketing India, Ranbaxy, Sun Pharma, US, generics, merger, recall, torrent
The US Federal Trade Commission has given its approval for Sun Pharma’s $4 billion acquisition of troubled Indian firm Ranbaxy …
Valeant recalls drug used on hospitalised infants
January 6, 2015Manufacturing and Production, Sales and Marketing Actavis, Allergan, FDA, Valeant, manufacturing, recall, ribavirin, virazole
North American drug firm Valeant Pharmaceuticals has issued a voluntary nationwide recall of Virazole due to microbial contamination. Virazole (ribavirin …
Ben Venue problems continue for Boehringer
September 2, 2014Manufacturing and Production, Sales and Marketing Ben Venue, Boehringer, fad, german, manufacturing, recall
Boehringer Ingelheim’s tribulations at its US production site Ben Venue Laboratories are refusing to leave as more of its products …
Sun Pharma recalls 40,000 bottles
July 14, 2014Manufacturing and Production Caraco Pharmaceutical Laboratories, FDA, Pfizer/Wyeth’s Effexor XR, Sun Pharma, antidepressant, recall
India-based manufacturer Sun Pharmaceutical Industries is recalling more than 40,000 bottles of its antidepressant venlafaxine hydrochloride, the US regulator has …
Dr Reddy’s recalls blood pressure drug
June 20, 2014Manufacturing and Production Dr Reddy's, India, blood pressure, metoprolol succinate, recall, toprol
Indian generics manufacturer Dr Reddy’s Laboratories is in the midst of recalling more than 13,000 bottles of blood pressure medicine …
Ranbaxy woes hit profits
May 13, 2014Manufacturing and Production, Sales and Marketing Q1, Ranbaxy, Sun Pharma, manufacturing, recall
Indian generics maker Ranbaxy Laboratories has slipped up in the first quarter of the year, with profit sliding to 0.3 …
Latest Sun Pharma recall blow for firm
May 9, 2014Manufacturing and Production Caraco, Cetirizine, Effexor, FDA, Sun Pharma, recall
India’s largest drugmaker Sun Pharmaceutical Industries is recalling almost 400,000 bottles of anti-depressant and antihistamine medications in the US, because …
Sun Pharma comes under FDA import alert
March 17, 2014Manufacturing and Production Sun Pharma, diabetes, gabapentin, manufacturing, metformin, recall
The reputation of India’s pharma sector has been dealt a further blow after yet another drugmaker was placed under an …
Merck recalls Liptruzet on packaging defects
January 20, 2014Manufacturing and Production FDA, Merck, US, liptruzet, recall
Merck & Co has been forced to undertake a massive recall of its combination cholesterol-lowering drug Liptruzet in the US …
FDA slaps import ban on Wockhardt facility
November 29, 2013Manufacturing and Production FDA, MHRA, Wockhardt, recall
The US Food and Drug Administration has banned imports of medicines made at Wockhardt’s Chikalthana plant in India that failed …
Novo recalls insulin shots on mis-dosing fears
October 28, 2013Manufacturing and Production Novo Nordisk, flexpen, novomix, recall
Novo Nordisk is recalling around 3 million insulin products used to treat diabetes in Europe because of a possible manufacturing …
MHRA recalls five Wockhardt medicines
October 18, 2013Manufacturing and Production FDA, GMP, MHRA, Violations, Wockhardt, recall
The UK drugs regulator has recalled five more generic medicines made by Indian drugmaker Wockhardt after an inspection uncovered quality …
FDA throws Ranbaxy a manufacturing lifeline
October 15, 2013Manufacturing and Production FDA, Ranbaxy, recall
Problems have plagued Ranbaxy’s manufacturing operations in the last couple of years, but it enjoyed a bit of light relief …
J&J’s manufacturing recovery hits a hurdle
September 10, 2013Manufacturing and Production API, J&J, JJ, McNeil, Motrin, recall
Johnson & Johnson’s path back to regulatory compliance in its manufacturing operations has hit another snag after the firm was …
Latest content
Five Facts about cardiovascular disease
